3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Conditions
Hyperthermia
20
Sarcoma
7
Uterine Cervical Neoplasms
4
Rectal Neoplasms
4
Prostatic Neoplasms
4
Head and Neck Neoplasms
4
Melanoma
3
Colonic Neoplasms
3
Carcinoma, Hepatocellular
3
Breast Neoplasms
3
Urinary Bladder Neoplasms
2
Ovarian Neoplasms
2
Neoplasms
2
Neoplasm Metastasis
2
Squamous Cell Carcinoma of Head and Neck
1
Solid Tumors
1
Sarcoma, Synovial
1
Sarcoma, Clear Cell
1
Sarcoma, Alveolar Soft Part
1
Salivary Gland Adenoma, Pleomorphic
1
Recurrence
1
Prehypertension
1
Prediabetic State
1
Polycystic Ovary Syndrome
1
Peritoneal Neoplasms
1
Pelvic Pain
1
Oropharyngeal Neoplasms
1
Obesity
1
Neurofibrosarcoma
1
Neoplasms, Radiation-Induced
1
Interventions
Metformin
7
Testosterone
2
Magnetic Resonance Spectroscopy
2
Inositol
2
Exercise
2
Ethinyl Estradiol
2
Blood Pressure
2
semaglutide
1
maltodextrin
1
drospirenone and ethinyl estradiol combination
1
drospirenone
1
bupropion hydrochloride, naltrexone hydrochoride drug combination
1
Walking
1
Vascular Stiffness
1
Ultrasonography
1
Triptorelin Pamoate
1
Topiramate
1
Tirzepatide
1
Sugars
1
Spironolactone
1
Qsymia
1
Pyruvic Acid
1
Pulse Wave Analysis
1
Preoperative Exercise
1
Pioglitazone
1
Phlebotomy
1
Phentermine
1
Pancreaticoduodenectomy
1
Orchiectomy
1
Naltrexone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Metabolic Syndrome
×
Diathermy
×
Clear all
NCT03644524
2018-08-23
CMH
University of Oregon
Phase NA
Completed
20 enrolled